BMJ1d
Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial
Department of Family Medicine and Community Health, New England Medical Cente, Tufts University School of Medicine, Boston, MA, USA Dr Kenneth C Gorson, Division of Neurology, St Elizabeth’s Medical ...
BMJ1d
Towards a multi-arm, multi-stage trial for disease modification in Parkinson’s: The EJS ACT-PD initiative
Background The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease initiative (EJS ACT-PD) is developing a multi-arm, multi-stage (MAMS) platform trial to accelerate identification of ...
BMJ1d
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I
1 Expert Centre Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands 2 Department of Clinical Neurophysiology, Institute of Neurology, Radboud University Nijmegen Medical ...
BMJ2d
Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study
Objective: There are only limited epidemiological studies evaluating the association between vertebrobasilar dolichoectasia (VBD) and outcomes. This study was designed to elucidate the outcome and ...
BMJ3d
Root compression on MRI compared with clinical findings in patients with recent onset cervical radiculopathy
1 Department of Neurology, Medical Centre Haaglanden, The Hague, The Netherlands 2 Department of Neurology, Maasstad Hospital, Rotterdam, The Netherlands 3 Department of Radiology, Medical Centre ...
BMJ6d
Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study
Dr JL Iddon, Department of Academic Neurosurgery, Box 167, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 5RG, UK email jo.iddon{at}cenes.co.uk OBJECTIVES Eleven patients ...
BMJ8d
Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryonic stem cells (ESCs), can be induced to differentiate to dopaminergic (DA) neurons, and hence be used ...
BMJ9d
Does the primary literature provide support for clinical signs used to distinguish psychogenic nonepileptic seizures from epileptic seizures?
Psychogenic non-epileptic seizures (PNES) represent a diagnostic challenge. When trying to distinguish between PNES and epileptic seizures (ES), clinicians rely on the presence or absence of several ...
BMJ10d
Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders
3 Working Group ‘Deep Brain Stimulation in Psychiatry: Guidance for Responsible Research and Application’. This Working Group is organised by the Europäische ...
BMJ10d
Trauma and depressive symptomatology in middle-aged persons at high risk of dementia: the PREVENT Dementia Study
Objective Depression and trauma are associated with changes in brain regions implicated in Alzheimer’s disease. The present study examined associations between childhood trauma, depression, adult ...
BMJ10d
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Correspondence to Dr Shyuan T Ngo, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia; s.ngo{at}uq.edu.au Objective To determine ...
BMJ10d
Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease
Background and objectives Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy and often presents during childhood. Guidelines for the optimal management of common problems ...